To determine whether active secretion by CAFs would induce directed collective tumor organoid migration, we utilized the microfluidic device described above but added CAFs expressing various DDR2 isoforms in the channel above the tumor organoids, which were in the central channel. The gene discussed is TBX1; the disease is neoplasm.